Discover how Bayesian non-parametric trajectory modeling identified seven combined FEV1 and FVC life-course trajectories and their association with airflow obstruction (AO) and PRISm. Learn about the prevalence and onset age across trajectories based on the Framingham Offspring Cohort study.
The relationship between airflow limitation severity and DNA methylation in COPD patients. Findings reveal CpGs with opposite associations in blood and lung tissues, highlighting distinct regulatory mechanisms.
Explore how the treatable traits approach can be applied to pre-COPD, potentially preventing full disease development. Learn about GETomics and its role in understanding pre-COPD through gene-environment interactions.
Discover the distinct patterns of epigenetic age acceleration in COPD patients. Our study reveals significant associations between airflow limitation severity and biological age in blood, highlighting different aging biomarkers in lung tissue.
La TM (telemedicina) podría ayudar en el tratamiento de la EPOC, pero aún queda un largo camino para poder implantar un sistema seguro a nivel nacional.
Descubre las innovaciones presentadas en el 57º Congreso SEPAR 2024. El Dr. Alvar Agustí, Catedrático de la Cátedra De Salud Respiratoria de la UB moderó: Aire de debate. Novedades en EPOC 2024
Explore how systemic inflammation differs between brain-dead (DBD) and circulatory-dead (DCD) lung donors and its impact on primary graft dysfunction (PGD) and mortality in lung transplant recipients.
Explore the link between Preserved Ratio Impaired Spirometry (PRISm) and arterial stiffness, highlighting significant findings from the Austrian LEAD study. Learn how PRISm impacts cardiovascular health.
Discover the relationships between symptoms and lung function in asthma and COPD from the NOVELTY study, highlighting key spirometry measures and their impact.
Aspergillus-associated disorders in bronchiectasis, based on data from the EMBARC Registry. ABPA, AS, and AB: Impact on disease severity, diagnostic criteria efficacy, etc.
